MNTA—Is there a more promising biotech company with an enterprise value of $275M or less (#msg-76922372, #msg-81239852)? If so, I’d like to know what it is.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”